Abbott earnings beat, but sales disappoint; Sanofi wins U.S. nod for Genzyme buy;

 @FiercePharma: Doc-payment database details industry ties. Story | Follow @FiercePharma

Special Report: Pharma's Biggest Flops. Report

Special Report: Pharma manufacturing consent decrees: 16 black holes. Report

> New test spots schizophrenia biomarkers. News

> Abbott Laboratories (ABT.N) reported quarterly earnings that slightly topped forecasts, helped by improved profit margins, but global sales of $8.68 billion fell short of Wall Street expectations. News

> Chinese researchers probe for biomarkers to guide Tarceva use. Article

> Sanofi Aventis (SASY.PA) got the green light from U.S. antitrust regulators to take over Genzyme (GENZ.O), if its buyout attempt does succeed. Report

> Forest Laboratories saw profit rise 53 percent in the fiscal second quarter compared with results that included a pair of hefty expenses a year ago. Article

> Gilead Sciences (GILD) announced that third-quarter earnings, on an adjusted basis, totaled $0.90, exceeding the $0.87 Wall Street consensus. The company earned $0.72 per share a year earlier. Story

> Generic drugmaker Mylan said a U.S. District Court denied its request for a preliminary injunction to block other companies from selling copycat versions of the antidepressant Paxil CR and it plans to appeal. Story

> A lead group of lawyers will get $315.3 million for doing most of the work on lawsuits against Merck over its Vioxx painkiller while other attorneys who filed suits will share $1.24 billion, a judge ruled. Item

> Pfizer opened a new biotechnology packaging facility in Hampshire, U.K., helping to make up for previous job cuts at the former Wyeth plant. News

Biotech News

 @FierceBiotech: Why are women thriving in the top ranks of biotech? Article | Follow @FierceBiotech

> Boehringer wins blockbuster Pradaxa approval. News

> Regulators green-light Sanofi's $18.5B Genzyme bid. Article

> Amylin shares crater after FDA rejects Bydureon app. Story 

Drug Delivery News

> New class of drugs could treat Alzheimer's. Report 

> Chinese company gets patent on diabetes controlled release. Article

> Implantable, drug-delivering LEDs ... maybe. Story

> Migraine sufferers get 'satisfaction' from Sumavel DosePro. News

> FDA rejects diabetes drug that includes Alkermes' delivery tech. Report

And Finally... Some leukemia patients may be effectively cured by taking modern cancer pills, giving a small minority of patients the option of discontinuing treatment, French researchers said. Report